ArticleQuantitative imaging in medicine and surgery2025
Dual-layer spectral detector computed tomography for adrenal adenoma characterization: radiation dose reduction and quantitative agreement of multiphase virtual noncontrast with true noncontrast imaging.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fat matters: practical imaging approach to microscopic and macroscopic fat in adrenal nodules.Abdominal radiology (New York) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Computed tomography (CT) is the preferred imaging modality for evaluating adrenal lesions; however, the associated radiation exposure remains a significant concern. Dual-layer spectral detector CT (SDCT)-derived virtual noncontrast (VNC) images may reduce radiation exposure by eliminating dedicated noncontrast scans, yet their agreement with true noncontrast (TNC) imaging remains debated. This study aimed to quantitatively evaluate the agreement and image quality of VNC images [reconstructed from the arterial phase (VNCa) and portal venous phase (VNCp)] compared to TNC images in adrenal adenomas stratified by lipid content, and to assess the radiation dose reduction. Methods: A total of 103 patients with adrenal adenomas treated at the Adrenal Disease Center of West China Hospital of Sichuan University between March 2023 and September 2024 were enrolled in this prospective study. All patients underwent dual-layer SDCT examination, including TNC and arterial and venous phase scans. VNC images were reconstructed from contrast-enhanced phases. Objective metrics, including CT attenuation value [Hounsfield units (HU)], noise (standard deviation), signal-to-noise ratio (SNR), contrast-to-noise ratio, and absolute attenuation error, and subjective image quality were compared. Interobserver agreement was assessed through the calculation of interclass correlation coefficients. For objective and subjective comparisons between TNC and VNC images, statistical analyses were performed with paired Results: This study included 103 patients (48 males and 55 females) with a mean age of 51.33±12.55 years. A total of 123 adrenal adenomas were identified, including 28 lipid-rich adenomas and 95 lipid-poor adenomas. For lipid-poor adenomas, VNC and TNC images showed excellent agreement in CT attenuation values (P>0.05), and compared to VNCp images, VNCa images exhibited significantly lower noise (17.44±3.39 Conclusions: Our findings suggest that for lipid-poor adenomas, VNCa demonstrates high agreement with TNC and provides superior image quality, supporting its use as a TNC substitute for reduced radiation dose. For lipid-rich adenomas, VNC should be applied with caution due to the potential risk of attenuation overestimation. Subtype classification remains essential in such studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.